SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-010359
Filing Date
2020-10-08
Accepted
2020-10-08 17:33:51
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1738
2 EX-24 ex24_rubius.htm EX-24 6989
  Complete submission text file 0001179110-20-010359.txt   10106
Mailing Address C/O INNOCOLL HOLDINGS PLC 3803 WEST CHESTER PIKE NEWTOWN SQUARE PA 19073
Business Address
Carmona Jose (Reporting) CIK: 0001693612 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38586 | Film No.: 201231638

Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)